{"transactions":[{"id":1113155,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T16:27:30.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":7238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":7238,"derivative":{"exercise_price":2.685,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":7238},"source":{"system":"sec-edgar","filing":"0000950170-25-085445","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000095017025085445/ownership.xml","form_type":"4"}},{"id":1113154,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T16:27:30.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":1689,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1689,"derivative":{"exercise_price":2.685,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":1689},"source":{"system":"sec-edgar","filing":"0000950170-25-085445","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000095017025085445/ownership.xml","form_type":"4"}},{"id":1113153,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T16:27:30.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":62728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":62728,"derivative":{"exercise_price":2.685,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":62728},"source":{"system":"sec-edgar","filing":"0000950170-25-085445","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000095017025085445/ownership.xml","form_type":"4"}},{"id":1488238,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T16:13:16.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":5209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":5209,"derivative":{"exercise_price":4.09,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":5209},"source":{"system":"sec-edgar","filing":"0000950170-24-069890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000095017024069890/ownership.xml","form_type":"4"}},{"id":1488237,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T16:13:16.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":1215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1215,"derivative":{"exercise_price":4.09,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":1215},"source":{"system":"sec-edgar","filing":"0000950170-24-069890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000095017024069890/ownership.xml","form_type":"4"}},{"id":1488236,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T16:13:16.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":40282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":40282,"derivative":{"exercise_price":4.09,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":40282},"source":{"system":"sec-edgar","filing":"0000950170-24-069890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000095017024069890/ownership.xml","form_type":"4"}},{"id":1835727,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T17:46:13.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":2744,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":2744},"source":{"system":"sec-edgar","filing":"0000950170-23-031789","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000095017023031789/ownership.xml","form_type":"4"}},{"id":1835726,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T17:46:13.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":640,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":640},"source":{"system":"sec-edgar","filing":"0000950170-23-031789","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000095017023031789/ownership.xml","form_type":"4"}},{"id":1835725,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T17:46:13.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":21222,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":21222},"source":{"system":"sec-edgar","filing":"0000950170-23-031789","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000095017023031789/ownership.xml","form_type":"4"}},{"id":2221052,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-27T06:42:17.000Z","date":"2022-06-23","kind":"purchase","acquired":true,"shares":4323,"price":3.4755,"value":15024.5865,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.475 to $3.4756, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":23967,"source":{"system":"sec-edgar","filing":"0000899243-22-024133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924322024133/doc4.xml","form_type":"4"}},{"id":2237551,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T17:07:25.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":6958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":6958,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":6958},"source":{"system":"sec-edgar","filing":"0000899243-22-021638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924322021638/doc4.xml","form_type":"4"}},{"id":2237550,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T17:07:25.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":1624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1624,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":1624},"source":{"system":"sec-edgar","filing":"0000899243-22-021638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924322021638/doc4.xml","form_type":"4"}},{"id":2237549,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T17:07:25.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":53812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":53812,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":53812},"source":{"system":"sec-edgar","filing":"0000899243-22-021638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924322021638/doc4.xml","form_type":"4"}},{"id":2673764,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T17:45:51.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1750,"derivative":{"exercise_price":12.97,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0000899243-21-023010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924321023010/doc4.xml","form_type":"4"}},{"id":2673763,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T17:45:51.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":408,"derivative":{"exercise_price":12.97,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":408},"source":{"system":"sec-edgar","filing":"0000899243-21-023010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924321023010/doc4.xml","form_type":"4"}},{"id":2673762,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T17:45:51.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":13534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":13534,"derivative":{"exercise_price":12.97,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":13534},"source":{"system":"sec-edgar","filing":"0000899243-21-023010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924321023010/doc4.xml","form_type":"4"}},{"id":3113215,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T17:47:49.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":4623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":4623,"derivative":{"exercise_price":5.02,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":4623},"source":{"system":"sec-edgar","filing":"0000899243-20-016181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924320016181/doc4.xml","form_type":"4"}},{"id":3113214,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T17:47:49.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":1079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1079,"derivative":{"exercise_price":5.02,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":1079},"source":{"system":"sec-edgar","filing":"0000899243-20-016181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924320016181/doc4.xml","form_type":"4"}},{"id":3113213,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T17:47:49.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":26503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":26503,"derivative":{"exercise_price":5.02,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":26503},"source":{"system":"sec-edgar","filing":"0000899243-20-016181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924320016181/doc4.xml","form_type":"4"}},{"id":3413782,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-16T16:15:22.000Z","date":"2019-09-12","kind":"purchase","acquired":true,"shares":1700,"price":5.8613,"value":9964.21,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.85 to $5.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":19644,"source":{"system":"sec-edgar","filing":"0000899243-19-023628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924319023628/doc4.xml","form_type":"4"}},{"id":3498783,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-06T17:35:26.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":3305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":3305,"derivative":{"exercise_price":7.06,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":3305},"source":{"system":"sec-edgar","filing":"0000899243-19-015820","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924319015820/doc4.xml","form_type":"4"}},{"id":3498782,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-06T17:35:26.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":771,"derivative":{"exercise_price":7.06,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":771},"source":{"system":"sec-edgar","filing":"0000899243-19-015820","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924319015820/doc4.xml","form_type":"4"}},{"id":3498781,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-06T17:35:26.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":18951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":18951,"derivative":{"exercise_price":7.06,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":18951},"source":{"system":"sec-edgar","filing":"0000899243-19-015820","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924319015820/doc4.xml","form_type":"4"}},{"id":3899827,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T16:35:49.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":2708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":2708,"derivative":{"exercise_price":8.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":2708},"source":{"system":"sec-edgar","filing":"0000899243-18-015766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924318015766/doc4.xml","form_type":"4"}},{"id":3899826,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T16:35:49.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":632,"derivative":{"exercise_price":8.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":632},"source":{"system":"sec-edgar","filing":"0000899243-18-015766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924318015766/doc4.xml","form_type":"4"}},{"id":3899825,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T16:35:49.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":15526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":15526,"derivative":{"exercise_price":8.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":15526},"source":{"system":"sec-edgar","filing":"0000899243-18-015766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924318015766/doc4.xml","form_type":"4"}},{"id":4285401,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T17:06:55.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":1037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1037,"derivative":{"exercise_price":5.15,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":1037},"source":{"system":"sec-edgar","filing":"0000899243-17-016104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924317016104/doc4.xml","form_type":"4"}},{"id":4285400,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T17:06:55.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":4444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":4444,"derivative":{"exercise_price":5.15,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":4444},"source":{"system":"sec-edgar","filing":"0000899243-17-016104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924317016104/doc4.xml","form_type":"4"}},{"id":4285399,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T17:06:55.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":17776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":17776,"derivative":{"exercise_price":5.15,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":17776},"source":{"system":"sec-edgar","filing":"0000899243-17-016104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924317016104/doc4.xml","form_type":"4"}},{"id":4435763,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":78550,"kind":"person","name":"JOYCE MARTIN JOSEPH","position":1,"cik":"0001300858","reported_name":"JOYCE MARTIN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-21T16:30:40.000Z","date":"2017-02-17","kind":"purchase","acquired":true,"shares":4444,"price":4.5,"value":19998.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017."}],"balance_after":17944,"source":{"system":"sec-edgar","filing":"0000899243-17-004752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300858/000089924317004752/doc4.xml","form_type":"4"}}]}